Clinical Trial Update: Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial suggests tolterodine may relieve symptoms of overactive bladder in women with moderate-to-severe obstructive sleep apnea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea
• Overactive Bladder

Drugs mentioned

• Tolterodine (tolterodine)

Snippet

Sponsor: Yuzuncu Yil University | Conditions: Overactive Bladder, Obstructive Sleep Apnea | Phase 4 | Status: COMPLETED